Firm & fund profile / Sourced portfolio
GSK
Tracked participation in 1 Atlas company, with 1 explicitly attributed lead.
1portfolio companies
1round participations
1lead positions
$15Mled round total
Conviction
Most recent leads
The latest rounds this investor is sourced as leading, newest first.
Capital activity
Portfolio
CompanyLatest valuationFirst → latestRoundsRoleAttributed partner
DateCompanyRoundRaisedValuationRoleEvidence
Dec 10, 2024RT
Relation TherapeuticsStrategic equity investment (from collaboration upfront)$15M—Lead
DateCompanyRoundRaisedValuationRoleEvidence
Dec 10, 2024RT
Relation TherapeuticsStrategic equity investment (from collaboration upfront)$15M—Lead